A Neuroinflammatory Model for Acute Fatigue During Exercise

Sports Medicine

Volumn 44, Issue 11, 2014, Pages 1479-1487

  Vargas, Nicole T ^a   Marino, Frank ^a  

^a CHARLES STURT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 7;

BLOOD; BRAIN; EXERCISE; FATIGUE; HUMAN; INFLAMMATION; METABOLISM; PHYSIOLOGY; SENSORY NERVE; SIGNAL TRANSDUCTION;

AFFERENT PATHWAYS; BRAIN; CYTOKINES; EXERCISE; FATIGUE; HUMANS; INFLAMMATION; INTERLEUKIN-7; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION;

EID: 84926648938     PISSN: 01121642     EISSN: 11792035     Source Type: Journal    
DOI: 10.1007/s40279-014-0232-4     Document Type: Editorial

References (76)

1. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J. 1993;7(8):678–86.
2. Coghill R, Talbot J, Evans A, et al. Distributed processing of pain and vibration by the human brain. J Neurosci. 1994;14(7):4095–108.
3. Liang M, Mouraux A, Iannetti GD. Parallel processing of nociceptive and non-nociceptive somatosensory information in the human primary and secondary somatosensory cortices: evidence from dynamic causal modeling of functional magnetic resonance imaging data. J Neurosci. 2011;31(24):8976–85.
4. Ploner M, Schmitz F, Freund H-J, et al. Parallel activation of primary and secondary somatosensory cortices in human pain processing. J Neurophysiol. 1999;81(6):3100–4.
5. Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev. 1998;105(1):83.
6. St Gibson A, Lambert E, Rauch LG, et al. The role of information processing between the brain and peripheral physiological systems in pacing and perception of effort. Sports Med. 2006;36(8):705–22.
7. Olofsson PS, Rosas-Ballina M, Levine YA, et al. Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev. 2012;248(1):188–204.
8. Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci. 1995;57(11):1011–26.
9. Vitkovic L, Konsman JP, Bockaert J, et al. Cytokine signals propagate through the brain. Mol Psychiatry. 2000;5(6):604.
10. St Clair Gibson A, Noakes TD. Evidence for complex system integration and dynamic neural regulation of skeletal muscle recruitment during exercise in humans. Br J Sports Med. 2004;38(6):797–806.
11. Lambert EV, St Clair Gibson A, TD Noakes. Complex systems model of fatigue: integrative homoeostatic control of peripheral physiological systems during exercise in humans. Br J Sports Med. 2005;39(1):52–62.
12. Dantzer R, O’Conner JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56.
13. Heesen C, Nawrath L, Reich C, et al. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry. 2006;77(1):34–9.
14. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis. 2005;5(11):718–25.
15. Hubbard JL, Mechan DJ. The physiology of health and illness: with related anatomy. UK: Stanley Thornes Ltd; 1997. p. 361–6.
16. Skoner DP, Gentile DA, Patel A, et al. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J Infect Dis. 1999;180(1):10–4.
17. Van Reeth K. Cytokines in the pathogenesis of influenza. Vet Microbiol. 2000;74(1–2):109–16.
18. Borish L, Schmaling K, DiClementi JD, et al. Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychologic variables. J Allergy Clin Immunol. 1998;102(2):222–30.
19. Buchwald D, Wener MH, Pearlman T, et al. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J Rheumatol. 1997;24(2):372–6.
20. Gupta S, Aggarwal S, See D, et al. Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J Psychiatr Res. 1997;31(1):149–56.
21. Chao CC, Gallagher M, Phair J, et al. Serum neopterin and interleukin-6 levels in chronic fatigue syndrome. J Infect Dis. 1990;162(6):1412–3.
22. Moss R, Mercandetti A, Vojdani A. TNF-α and chronic fatigue syndrome. J Clin Immunol. 1999;19(5):314–6.
23. Patarca R, Klimas N, Sandler D, et al. Interindividual immune status variation patterns in patients with chronic fatigue syndrome. J Chronic Fatigue Syndr. 1996;2(1):13–39.
24. Robson-Ansley P, Cockburn E, Walshe I, et al. The effect of exercise on plasma soluble IL-6 receptor concentration: a dichotomous response. Exerc Immunol Rev. 2010;16:56–76.
25. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002;13(4–5):357–68.
26. Rovaris M, Barnes D, Woodrofe N, et al. Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups. J Neurol. 1996;243(7):536–42.
27. Robson-Ansley P, Barwood M, Canavan J, et al. The effect of repeated endurance exercise on IL-6 and sIL-6R and their relationship with sensations of fatigue at rest. Cytokine. 2009;45(2):111–6.
28. Gray SR, Clifford M, Lancaster R, et al. The response of circulating levels of the interleukin-6/interleukin-6 receptor complex to exercise in young men. Cytokine. 2009;47(2):98–102.
29. Kreher JB, Schwartz JB. Overtraining syndrome: a practical guide. Sports health: a multidisciplinary approach. 2012;4(2):128–38.
30. Robson-Ansley P, Blannin A, Gleeson M. Elevated plasma interleukin-6 levels in trained male triathletes following an acute period of intense interval training. Eur J Appl Physiol. 2007;99(4):353–60.
31. Allen DG, Lamb GD, Westerblad H. Skeletal muscle fatigue: cellular mechanisms. Physiol Rev. 2008;88(1):287–332.
32. Grange RW, Houston ME. Simultaneous potentiation and fatigue in quadriceps after a 60-second maximal voluntary isometric contraction. J Appl Physiol. 1991;70(2):726–31.
33. Kent-Braun JA. Central and peripheral contributions to muscle fatigue in humans during sustained maximal effort. Euro J Appl Physiol. 1999;80(1):57–63.
34. Gandevia SC, Allen GM, Butler JE, et al. Supraspinal factors in human muscle fatigue: evidence for suboptimal output from the motor cortex. J Physiol. 1996;490:529–36.
35. Martin PG, Smith JL, Butler JE, et al. Fatigue-sensitive afferents inhibit extensor but not flexor motoneurons in humans. J Neurosci. 2006;26(18):4796–802.
36. Wiles CM, Edwards RHT. The effect of temperature, ischaemia and contractile activity on the relaxation rate of human muscle. Clin Physiol. 1982;2(6):485–97.
37. Kennedy DS, McNeil CJ, Gandevia SC, et al. Firing of antagonist small-diameter muscle afferents reduces voluntary activation and torque of elbow flexors. J Physiol. 2013;591(14):3591–604.
38. Holloszy J. Regulation by exercise of skeletal muscle content of mitochondria and GLUT4. J Physiol Pharmacol. 2008;59(Suppl 7):5–18.
39. Febbraio MA, Hiscock N, Sacchetti M, et al. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes. 2004;53(7):1643–8.
40. Mendham A, Donges C, Liberts E, et al. Effects of mode and intensity on the acute exercise-induced IL-6 and CRP responses in a sedentary, overweight population. Eur J Appl Physiol. 2011;111(6):1035–45.
41. Mendham A, Coutts A, Duffield R. The acute effects of aerobic exercise and modified rugby on inflammation and glucose homeostasis within Indigenous Australians. Eur J Appl Physiol. 2012;112(11):3787–95.
42. Starkie RL, Arkinstall MJ, Koukoulas I, et al. Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol. 2001;533(2):585–91.
43. Ostrowski K, Rohde T, Zacho M, et al. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol. 1998;508(3):949–53.
44. Robson-Ansley PJ, Milander Ld, Collins M, et al. Acute Interleukin-6 administration impairs athletic performance in healthy, trained male runners. Can J Appl Physiol. 2004;29(4):411–8.
45. Taga T, Kishimoto T. gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997;15(1):797.
46. Andratsch M, Mair N, Constantin CE, et al. A key role for gp130 expressed on peripheral sensory nerves in pathological pain. J Neurosci. 2009;29(43):13473–83.
47. Jones SA, Richards PJ, Scheller J, et al. Review: IL-6 transsignaling: the in vivo consequences. J Interferon Cytokine Res. 2005;25(5):241–53.
48. Gleeson M. Anti-inflammatory effects of exercise. Obesity, inflammation and cancer. New York: Springer; 2013. p. 401–24.
49. Papanicolaou DA, Wilder RL, Manolagas SC, et al. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998;128(2):127–37.
50. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett. 2004;361(1–3):184–7.
51. Gray SR, Robinson M, Nimmo MA. Response of plasma IL-6 and its soluble receptors during submaximal exercise to fatigue in sedentary middle-aged men. Cell Stress Chaperones. 2008;13(2):247–51.
52. Patterson S, Reid S, Gray S, et al. The response of plasma interleukin-6 and its soluble receptors to exercise in the cold in humans. J Sports Sci. 2008;26(9):927–33.
53. Robinson M, Gray SR, Watson MS, et al. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome. Scand J Med Sci Sports. 2010;20(2):282–90.
54. Brenn D, Richter F, Schaible H-G. Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. Arthritis Rheum. 2007;56(1):351–9.
55. Chichorro JG, Lorenzetti BB, Zampronio AR. Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats. Br J Pharmacol. 2004;141(7):1175–84.
56. Cunha JM, Cunha FQ, Poole S, et al. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol. 2000;130(6):1418–24.
57. Albrecht PJ, Rice FL. Role of small-fiber afferents in pain mechanisms with implications on diagnosis and treatment. Curr Pain Headache Rep. 2010;14(3):179–88.
58. Roth J, Harre EM, Rummel C, et al. Signaling the brain in systemic inflammation: role of sensory circumventricular organs. Front Biosci. 2004;1(9):290–300.
59. Bear MF, Connors BW, Paradiso MA. Neuroscience: exploring the brain. 3rd ed. USA: Lippincott Williams and Wilkins; 2006. p. 413–4.
60. Luc Darques J, Decherchi P, Jammes Y. Mechanisms of fatigue-induced activation of group IV muscle afferents: the roles played by lactic acid and inflammatory mediators. Neurosci Lett. 1998;257(2):109–12.
61. Chester AR, Kathryn HG. Augmentation of exercise-induced muscle sympathetic nerve activity during muscle heating. J Appl Physiol. 1997;82(6):1719–33.
62. Goehler LE, Gaykema RPA, Hansen MK, et al. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci. 2000;85(1–3):49–59.
63. Immke DC, McCleskey EW. Lactate enhances the acid-sensing Na+ channel on ischemia-sensing neurons. Nat Neurosci. 2001;4(9):869–70.
64. Gautam M, Benson CJ, Sluka KA. Increased response of muscle sensory neurons to decreases in pH after muscle inflammation. Neurosci. 2010;170(3):893–900.
65. Street D, Bangsbo J, Juel C. Interstitial pH in human skeletal muscle during and after dynamic graded exercise. J Physiol. 2001;537(3):993–8.
66. Yquel RJ, Arsac LM, Thiaudiere E, et al. Effect of creatine supplementation on phosphocreatine resynthesis, inorganic phosphate accumulation and pH during intermittent maximal exercise. J Sports Sci. 2002;20(5):427–37.
67. Cunha FQ, Poole S, Lorenzetti BB, et al. The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia. Br J Pharmacol. 1992;107(3):660–4.
68. Hoheisel U, Unger T, Mense S. Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the rat. Pain. 2005;114(1–2):168–76.
69. Vissers KC, De Jongh RF, Hoffmann VL, et al. Exogenous interleukin-6 increases cold allodynia in rats with a mononeuropathy. Cytokine. 2005;30(4):154–9.
70. Vallières L, Rivest S. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1β. J Neurochem. 1997;69(4):1668–83.
71. Quan N, Stern EL, Whiteside MB, et al. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J Neuroimmunol. 1999;93(1–2):72–80.
72. Nybo L, Nielsen B, Pedersen BK, et al. Interleukin-6 release from the human brain during prolonged exercise. J Physiol. 2002;1(542):991–5.
73. Phelps EA, LeDoux JE. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron. 2005;48(2):175–87.
74. Hall EE, Ekkekakis P, Petruzzello SJ. Regional brain activity and strenuous exercise: predicting affective responses using EEG asymmetry. Biol Psychol. 2007;75(2):194–200.
75. Nielsen B, Hyldig T, Bidstrup F, et al. Brain activity and fatigue during prolonged exercise in the heat. Pflügers Arch. 2001;442(1):41–8.
76. Nybo L, Nielsen B. Perceived exertion is associated with an altered brain activity during exercise with progressive hyperthermia. J Appl Physiol. 2001;91(5):2017–23.